Somatic mutations in BIRC2/BIRC3, TRAF2/TRAF3 and NOTCH1 are described to affect the B-cell and NFκ-B signalling pathways and are associated with aggressive disease in patients with MCL [22, 23]. Here, NFKB1 is linked to mantle cell lymphoma.